Thiard News@F4F

@newsen.bsky.social

1 week ago

Genprex's Reqorsa® Gene Therapy Shows Promise for Lung Cancer in Upcoming AACR 2026 Presentation Genprex, Inc. plans to showcase encouraging preclinical findings on Reqorsa®, a gene therapy for lung cancer, at AACR 2026. Key biomarkers related to therapy response will be discussed.

Genprex's Reqorsa® Gene Therapy Shows Promise for Lung Cancer in Upcoming AACR 2026 Presentation #United_States #San_Diego #Lung_Cancer #Genprex #Reqorsa

Thiard News@F4F

@newsen.bsky.social

1 month ago

Genprex Expands Intellectual Property For Cancer Gene Therapy Through Patents In Japan And EU Genprex, Inc. announces patent grants from Japan and the EU for its Reqorsa® gene therapy combined with immunotherapy, enhancing cancer treatment options.

Genprex Expands Intellectual Property For Cancer Gene Therapy Through Patents In Japan And EU #United_States #Austin,_Texas #oncology #Genprex #Reqorsa

Thiard News@F4F

@newsen.bsky.social

1 month ago

Genprex's Patent Approval for Reqorsa® Gene Therapy Enhances Cancer Treatment Potential Genprex, Inc. has secured a patent intent for Reqorsa® gene therapy in combination with PD-L1 antibodies against cancer. This move strengthens their intellectual property.

Genprex's Patent Approval for Reqorsa® Gene Therapy Enhances Cancer Treatment Potential #United_States #Austin #Genprex #Reqorsa #GNPX

Thiard News@F4F

@newsen.bsky.social

2 months ago

Genprex Achieves Significant Milestones in Diabetes Gene Therapy Innovations for Type 1 and Type 2 Diabetics Genprex, Inc. has announced major advancements in its diabetes gene therapy program, particularly with GPX-002, to treat Type 1 and Type 2 diabetes. Discover their latest developments.

Genprex Achieves Significant Milestones in Diabetes Gene Therapy Innovations for Type 1 and Type 2 Diabetics #United_States #Austin #Genprex #GPX-002 #diabetes_gene_therapy

Thiard News@F4F

@newsen.bsky.social

2 months ago

Breakthrough in Diabetes Treatment: Genprex Unveils Promising Data for Gene Therapy GPX-002 Genprex, Inc. revealed significant preliminary findings for GPX-002, a revolutionary gene therapy addressing Type 2 diabetes, featuring animal study advancements.

Breakthrough in Diabetes Treatment: Genprex Unveils Promising Data for Gene Therapy GPX-002 #Genprex #GPX-002 #diabetes_gene_therapy

Thiard News@F4F

@newsen.bsky.social

4 months ago

Genprex Unveils Promising Results from Acclaim-1 Phase 1 Clinical Trial in Lung Cancer Genprex, Inc. announces significant findings from the Acclaim-1 Phase 1 trial of Reqorsa gene therapy combined with Tagrisso, offering hope for lung cancer patients.

Genprex Unveils Promising Results from Acclaim-1 Phase 1 Clinical Trial in Lung Cancer #United_States #Austin #Genprex #Reqorsa #TAGRISSO

Thiard News@F4F

@newsen.bsky.social

4 months ago

Genprex Expands Clinical Trial Sites for Innovative Lung Cancer Treatment Genprex enhances its lung cancer clinical trials by adding the Gabrail Cancer Center as a site. This move aims to boost patient enrollment for their gene therapy treatments.

Genprex Expands Clinical Trial Sites for Innovative Lung Cancer Treatment #USA #Canton #Genprex #Reqorsa #Acclaim_Trials

Thiard News@F4F

@newsen.bsky.social

4 months ago

Genprex Secures European Patent for Innovative Gene Therapy to Combat Cancer Genprex Inc. has announced the European Patent Office's decision to grant a patent for its Reqorsa® Gene Therapy combined with PD-1 antibodies, enhancing cancer treatment options.

Genprex Secures European Patent for Innovative Gene Therapy to Combat Cancer #USA #Austin #Genprex #Reqorsa #PD-1_Antibodies

Thiard News@F4F

@newsen.bsky.social

5 months ago

Genprex Initiates $10 Million Direct Offering to Fund Cancer and Diabetes Therapies Genprex, Inc. announces a registered direct offering of up to $10 million to support its gene therapy advancements for cancer and diabetes treatment.

Genprex Initiates $10 Million Direct Offering to Fund Cancer and Diabetes Therapies #gene_therapy #Genprex #GNPX

Thiard News@F4F

@newsen.bsky.social

5 months ago

Genprex Unveils Promising Data for Reqorsa® Gene Therapy at Major Cancer Conference At the AACR-NCI-EORTC conference, Genprex showcased groundbreaking preclinical results for Reqorsa® Gene Therapy, targeting lung cancer treatment. New findings suggest enhanced patient outcomes.

Genprex Unveils Promising Data for Reqorsa® Gene Therapy at Major Cancer Conference #Genprex #Reqorsa #ALK-EML4

Thiard News@F4F

@newsen.bsky.social

5 months ago

Genprex Secures Up to $8.1 Million Through Direct Offering for Innovative Gene Therapy Initiatives Genprex, Inc. announces a direct offering to raise up to $8.1 million to expedite its innovative gene therapy developments for cancer and diabetes.

Genprex Secures Up to $8.1 Million Through Direct Offering for Innovative Gene Therapy Initiatives #United_States #Austin #gene_therapy #Genprex #GNPX

Thiard News@F4F

@newsen.bsky.social

5 months ago

Genprex Sets the Stage with Promising Data for Reqorsa® Gene Therapy at 2025 AACR-NCI-EROTC Conference Genprex's Reqorsa® gene therapy shows promise in treating lung cancer, with exciting preclinical data to be presented at the 2025 conference.

Genprex Sets the Stage with Promising Data for Reqorsa® Gene Therapy at 2025 AACR-NCI-EROTC Conference #USA #Austin #Lung_Cancer #Genprex #Reqorsa

Thiard News@F4F

@newsen.bsky.social

5 months ago

Genprex to Showcase Promising Data on Reqorsa® for Lung Cancer Treatment at AACR-NCI-EROTC Conference Genprex will present promising preclinical findings on Reqorsa® Gene Therapy for lung cancer at the upcoming conference, illustrating its potential as a transformative treatment.

Genprex to Showcase Promising Data on Reqorsa® for Lung Cancer Treatment at AACR-NCI-EROTC Conference #United_States #Boston #Lung_Cancer #Genprex #Reqorsa

Thiard News@F4F

@newsen.bsky.social

6 months ago

Genprex to Showcase Innovative Gene Therapies at September Conferences Genprex, Inc. is set to highlight its groundbreaking gene therapies for cancer and diabetes at major investor conferences in September 2025.

Genprex to Showcase Innovative Gene Therapies at September Conferences #United_States #New_York_City #Genprex #diabetes #Cancer

Thiard News@F4F

@newsen.bsky.social

7 months ago

Genprex Expands Patent Portfolio for Gene Therapy on Cancer Innovations Genprex, Inc. strengthens its cancer treatment capabilities by securing multiple patents for Reqorsa® Gene Therapy, enhancing immune checkpoint blockers.

Genprex Expands Patent Portfolio for Gene Therapy on Cancer Innovations #USA #Austin #Genprex #Reqorsa #PD-L1

Thiard News@F4F

@newsen.bsky.social

7 months ago

Genprex Highlights Advancements in Gene Therapy: 2025 Corporate Insights Genprex, Inc. provides significant updates and outlines their ongoing clinical efforts for 2025, emphasizing milestones in cancer and diabetes therapies.

Genprex Highlights Advancements in Gene Therapy: 2025 Corporate Insights #USA #Austin #Cancer_Treatment #gene_therapy #Genprex

Thiard News@F4F

@newsen.bsky.social

9 months ago

Genprex's Breakthrough in Diabetes Gene Therapy Showcased at 2025 ADA Scientific Sessions Genprex presents its promising diabetes gene therapy research at the ADA 85th Scientific Sessions, focusing on revolutionary treatments for diabetes.

Genprex's Breakthrough in Diabetes Gene Therapy Showcased at 2025 ADA Scientific Sessions #USA #Chicago #Genprex #GPX-002 #DiabetesGeneTherapy

Thiard News@F4F

@newsen.bsky.social

9 months ago

Genprex Advances Diabetes Gene Therapy Using Innovative Non-Viral Methods at 2025 ADA Sessions Genprex has presented groundbreaking research at the 2025 American Diabetes Association sessions, showcasing a novel non-viral delivery system for diabetes gene therapy.

Genprex Advances Diabetes Gene Therapy Using Innovative Non-Viral Methods at 2025 ADA Sessions #USA #Chicago #lipid_nanoparticles #Genprex #diabetes

Thiard News@F4F

@newsen.bsky.social

10 months ago

Genprex to Showcase Acclaim-3 Trial Design Evaluating Reqorsa® for Lung Cancer at ASCO 2025 Genprex will present the Acclaim-3 clinical trial design for its Reqorsa® gene therapy targeting extensive stage small cell lung cancer at the ASCO Annual Meeting in 2025.

Genprex to Showcase Acclaim-3 Trial Design Evaluating Reqorsa® for Lung Cancer at ASCO 2025 #United_States #Chicago #Genprex #Reqorsa #ASCO2025

Thiard News@F4F

@newsen.bsky.social

10 months ago

Genprex Showcases Groundbreaking Diabetes Gene Therapy Data at ASGCT Meeting Genprex's promising diabetes gene therapy GPX-002 showcases positive preclinical data at the ASGCT 28th Annual Meeting, sparking hope for diabetes patients.

Genprex Showcases Groundbreaking Diabetes Gene Therapy Data at ASGCT Meeting #USA #Austin #Genprex #diabetes #GPX-002

Thiard News@F4F

@newsen.bsky.social

10 months ago

Genprex and University of Pittsburgh Collaborate on Gene Therapy Research for Diabetes Treatment Genprex and the University of Pittsburgh expand their collaboration to explore a gene therapy for treating Type 1 and Type 2 diabetes through new studies.

Genprex and University of Pittsburgh Collaborate on Gene Therapy Research for Diabetes Treatment #United_States #Austin #gene_therapy #Genprex #diabetes

Thiard News@F4F

@newsen.bsky.social

10 months ago

Genprex Expands Its Gene Therapy Portfolio with Exclusive Licensing Agreement for Glioblastoma Treatment Genprex has secured an exclusive license agreement with UTHealth Houston for advanced gene therapy technology aimed at treating glioblastoma. This moves the company's treatment options forward significantly.

Genprex Expands Its Gene Therapy Portfolio with Exclusive Licensing Agreement for Glioblastoma Treatment #United_States #Austin #Genprex #Reqorsa #UTHealth

Thiard News@F4F

@newsen.bsky.social

11 months ago

Genprex Unveils Promising Results for Reqorsa Gene Therapy at AACR 2025 Genprex shares encouraging preclinical results for Reqorsa gene therapy in tackling Ras inhibitor-resistant lung cancer at the AACR 2025 event.

Genprex Unveils Promising Results for Reqorsa Gene Therapy at AACR 2025 #USA #Chicago #Genprex #Reqorsa #AACR_2025

Thiard News@F4F

@newsen.bsky.social

11 months ago

Genprex Unveils Promising Diabetes Gene Therapy Data at ASGCT Meeting Genprex, Inc. is set to present remarkable preclinical data on GPX-002, a groundbreaking gene therapy for diabetes, during the ASGCT Annual Meeting in New Orleans.

Genprex Unveils Promising Diabetes Gene Therapy Data at ASGCT Meeting #United_States #Austin #Genprex #GPX-002 #Diabetes_Therapy

Thiard News@F4F

@newsen.bsky.social

11 months ago

Genprex Partners with NYU Langone Health for Mesothelioma Treatment Breakthrough Genprex has formed an exclusive agreement with NYU Langone Health for its Reqorsa gene therapy, targeting difficult-to-treat mesothelioma. This partnership aims to advance clinical studies and enhance treatment options.

Genprex Partners with NYU Langone Health for Mesothelioma Treatment Breakthrough #United_States #Austin #NYU_Langone #Genprex #Reqorsa

Thiard News@F4F

@newsen.bsky.social

11 months ago

Genprex Announces Presentation of Acclaim-3 Clinical Trial Design at ASCO 2025 Genprex, Inc. will present its trial design for Acclaim-3, examining Reqorsa Gene Therapy for lung cancer, at the 2025 ASCO Annual Meeting.

Genprex Announces Presentation of Acclaim-3 Clinical Trial Design at ASCO 2025 #USA #Chicago #Genprex #Reqorsa #Acclaim-3

Thiard News@F4F

@newsen.bsky.social

1 year ago

Genprex to Showcase Promising Data on Reqorsa® Gene Therapy for Lung Cancer at AACR Annual Meeting 2025 At the upcoming 2025 AACR Annual Meeting, Genprex will present encouraging preclinical findings on Reqorsa®, a gene therapy aimed at treating lung cancer, showcasing innovative cancer treatment potential.

Genprex to Showcase Promising Data on Reqorsa® Gene Therapy for Lung Cancer at AACR Annual Meeting 2025 #United_States #Chicago #Lung_Cancer #Genprex #Reqorsa

Thiard News@F4F

@newsen.bsky.social

1 year ago

Genprex's Upcoming Participation at BIO Europe Spring 2025 Event Genprex, a gene therapy leader, will engage in BIO Europe Spring 2025 in Milan. Meet their team to learn about innovative treatments.

Genprex's Upcoming Participation at BIO Europe Spring 2025 Event #United_States #Austin #gene_therapy #Genprex #BIO_Europe_Spring

Thiard News@F4F

@newsen.bsky.social

1 year ago

Genprex Makes Significant Progress in Diabetes Gene Therapy Research with Non-Viral Delivery System Genprex, Inc. is enhancing its diabetes gene therapy initiatives through a strategic partnership to explore non-viral delivery methods, aiming to revolutionize treatment options.

Genprex Makes Significant Progress in Diabetes Gene Therapy Research with Non-Viral Delivery System #United_States #Austin #gene_therapy #Genprex #diabetes

Thiard News@F4F

@newsen.bsky.social

1 year ago

Genprex Advances Diabetes Gene Therapy with New License Agreement and Subsidiary Genprex, Inc. provides an update on its diabetes gene therapy program, highlighting a new exclusive license with the University of Pittsburgh and the formation of a subsidiary.

Genprex Advances Diabetes Gene Therapy with New License Agreement and Subsidiary #United_States #Austin #gene_therapy #Genprex #diabetes